GeneHarbor Hong Kong Biotechnologies LimitedProfilePic621

基因港 (香港) 生物科技有限公司

此内容只提供英文版本

公司

GeneHarbor (Hong Kong) Biotechnologies Limited works on active pharmaceutical ingredients [API] and/or intermediates via enzymatic approach, servicing pharma manufacturing. The company has developed a proprietary platform technology for production of various enzymes.  The technology aims to reduce the cost & increase the life span of the enzymes.  The company is developing a novel technology for purification of monoclonal antibodies.  This will facilitate the development of monoclonal antibody drugs in the future.